The levels of markers of myocardial hypertrophy, including atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and myosin heavy chain beta (β-MHC), were increased in the DCM group. This evidence concerns the gene NPPA and cardiac hypertrophy.